(Q42752134)

6 November 2017

title

Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases (English)

1 reference

6 November 2017

1 reference

Yukihiko Sonoda

4

0 references

author name string

Tomoo Inoue

1

1 reference

6 November 2017

Toshihiro Kumabe

2

1 reference

6 November 2017

Masayuki Kanamori

3

1 reference

6 November 2017

Mika Watanabe

5

1 reference

6 November 2017

Teiji Tominaga

6

1 reference

6 November 2017

language of work or name

1 reference

1 April 2010

1 reference

6 November 2017

1 reference

6 November 2017

volume

34

1 reference

6 November 2017

issue

2

1 reference

6 November 2017

page(s)

197-208

1 reference

Gliomatosis cerebri: 20 years of experience at the Children's Hospital of Philadelphia

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Possible efficacy of temozolomide in a patient with gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: quantitative proof of vessel recruitment by cooptation instead of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

The course of neurocognitive functioning in high-grade glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

On the interpretation of proton NMR spectra from brain tumours in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Factors influencing survival in high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: better definition, better treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Correlative analysis of gene expression profile and prognosis in patients with gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: treatment results with radiotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Fluid-attenuated inversion-recovery MR imaging of gliomatosis cerebri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri presenting with optic nerve involvement: MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

CT and MRI findings in gliomatosis cerebri: a neuroradiologic and neuropathologic review of diffuse infiltrating brain neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

1H MR spectroscopy in the assessment of gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Secondary glioblastoma remarkably reduced by steroid administration after anaplastic transformation from gliomatosis cerebri--case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Radiation therapy approach in gliomatosis cerebri--case reports and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri in a 10-year-old girl masquerading as diffuse encephalomyelitis and spinal cord tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri presenting as intractable epilepsy during early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri with secondary glioblastoma formation: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Magnetic resonance spectroscopy: a noninvasive diagnosis of gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: clinical features, treatment, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

The prognostic value of cognitive functioning in the survival of patients with high-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri angiographically mimicking central nervous system angiitis: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis of the brain and spinal cord masquerading as infective lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Cognitive function as a predictor of survival in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Role of proton magnetic resonance spectroscopy in the diagnosis of gliomatosis cerebri: a unique pattern of normal choline but elevated Myo-inositol metabolite levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

A serial CT scan and MRI verification of diffuse cerebrospinal gliomatosis: a case report with stereotactic diagnosis and radiological confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Human brain tumors: assessment with in vivo proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: improved outcome with radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: findings with computed tomography and magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri with formation of a glioblastoma multiform. Study and follow-up by magnetic resonance and computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Diagnosis and management of gliomatosis cerebri: recent trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Initial chemotherapy in gliomatosis cerebri.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: bioptical approach and neuropathological verification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: comparison of MR and CT features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Long-term survivors of glioblastoma: clinical features and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri, report of a clinically diagnosed and histologically confirmed case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Gliomatosis cerebri: a review of 22 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

Genetic aberrations in gliomatosis cerebri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10143-010-0306-1

MR spectroscopy in gliomatosis cerebri

21 January 2018

1 reference

12 December 2020

Posterior fossa decompression for life-threatening tonsillar herniation in patients with gliomatosis cerebri: report of three cases.

1 reference

12 December 2020

Proton MR spectroscopy in gliomatosis cerebri

1 reference

12 December 2020

The transformation of pediatric gliomatosis cerebri to cerebellar glioblastoma multiforme presenting as supra- and infratentorial acute disseminated encephalomyelitis. Case report.

1 reference

12 December 2020

Proton magnetic resonance spectroscopy (1H-MRS) for the evaluation of treatment of brain tumours.

1 reference

12 December 2020

Gliomatosis cerebri: cytologic and autopsy findings in a case involving the entire neuraxis

1 reference

12 December 2020

Gliomatosis cerebri: clinicopathologic study of 33 cases and comparison of mass forming and diffuse types

1 reference

12 December 2020

[An autopsy case of gliomatosis cerebri with marked swelling of the spinal cord]

1 reference

12 December 2020

Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels

1 reference

12 December 2020

Gliomatosis cerebri involving the lumbosacral spinal cord.

1 reference

12 December 2020

Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.

1 reference

12 December 2020

Gliomatosis Cerebri: Neurobehavioral and Neuropathological Observations

1 reference

12 December 2020

10.1007/S10143-010-0306-1

Identifiers

DOI

1 reference

6 November 2017

1 reference